Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

Diraison, F, Moulin, Ph, Beylot, M · 2003 · Diabetes & Metabolism

Abstract

Background Non-alcoholic fatty liver disease (NAFLD) is frequently observed in insulin-resistant subjects and can lead to liver fibrosis and cirrhosis. The abnormalities of lipid metabolism behind this development of excess hepatic TG stores are poorly understood.Methods To clarify these mechanisms we measured triglyceride secretion rate and the contributions of hepatic lipogenesis and reesterification of non-esterified fatty acids (NEFA) to this secretion in healthy subjects and in patients with clear evidence of NAFLD. All subjects were studied in the post-absorptive state. Hepatic lipogenesis was measured with deuterated water. NEFA turnover rate, triglyceride secretion rate and the contribution of NEFA reesterification to this secretion were determined with [1-(13)C] palmitate infusion.Results NAFLD patients had higher NEFA concentrations (p<0.05) but normal NEFA turnover rates (5.23 +/- 0.80 vs 5.91 +/- 0.97 micromol.kg(-1).min(-1) in control subjects, ns). Despite a trend for higher plasma triglyceride levels in patients (p<0.10), triglyceride turnover rates were not increased (0.11 +/- 0.01 micromol.kg(-1).min(-1) in patients vs 0.14 +/- 0.01 in controls, ns). However the contribution of hepatic lipogenesis to triglyceride secretion was largely increased in patients (14.9 +/- 2.7 vs 4.6 +/- 1.1% p<0.01) while that of NEFA reesterification was reduced (25.1 +/- 2.9 vs 52.8 +/- 6.2% p<0.01).Conclusion Enhanced lipogenesis appears as a major abnormality of hepatic fatty metabolism in subjects with NAFLD. Therapeutic measures aimed at decreasing hepatic lipogenesis would therefore be the most appropriate in order to reduce hepatic TG synthesis and content in such patients.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1262-3636(07)70061-7

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Lewis, 1995, Interaction between free fatty acids and insulin in the acute control of VLDL production in humans, J Clin Invest, 96, 135

Cited by

See all 435

Metadata

Authors
Diraison, F., Moulin, P., & Beylot, M.
Affiliations
  • Inserm (FR)
  • Hôpital Louis Pradel (FR)
Corresponding author
Beylot, M
Venue
Diabetes & Metabolism
Publisher
Elsevier BV
Published
2003-11
Volume
29
Issue
5
Pages
478-485
ISSN
1262-3636 (ISSN-L)
OpenAlex
W2089369126
Cited by
435
References
49
Citations by year
2026: 8 · 2025: 15 · 2024: 12 · 2023: 21 · 2022: 23 · 2021: 29 · 2020: 16 · 2019: 27 · 2018: 29 · 2017: 23 · 2016: 20 · 2015: 29 · 2014: 21 · 2013: 24 · 2012: 21
FWCI
4.68
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Diabetes & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
non-alcoholic fatty liver disease, hepatic de novo lipogenesis, triglyceride secretion, free fatty acids, fatty acid re-esterification, triglyceride synthesis, hepatic lipid metabolism, insulin resistance, heavy water, fatty acid turnover, liver fibrosis, liver cirrhosis
MeSH terms
Adult, Carbon Isotopes, Cholesterol, Fatty Acids, Nonesterified, Fatty Liver, Female, Glucagon, Humans, Insulin, Isotope Labeling, Lipid Mobilization, Liver, Male, Middle Aged, Reference Values, Triglycerides, Palmitic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1016/s1262-3636(07)70061-7
The paper
Diraison, F., Moulin, P., & Beylot, M. (2003). Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes & Metabolism. https://doi.org/10.1016/s1262-3636(07)70061-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.